1[1]Munclinger MJ, Patel .JJ, Mitha AS. Follow-up of patients witharrhythmogenic right ventricular cardiomyopathy dysplasia. S AfrMed J,2000,1990(1) :61～68.
2[2]Myrianthefs M, Cariolou M, Eldar M, et al. Exercise-inducedventricular arrhythmias and sudden cardiac death in a family.Chest,1997,111(4) :1 130～134.
3[3]Hermida JS, Minassian A, .larry G, et al. Familial incidence oflate ventricular potentials and electrocardiographic abnonnalitiesin arrhythmogenic right venicular dysplasia. An J cardiol,1997,79(10):1 375～1 380.
4[4]Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenie right ventricular cardiomnyopathy/dysplasia: a multicenter study. J Am Coll Cardiol1997,30(6):1 512～1 520.
5[5]Kazmierczak J, De Sutter J, Tavemier R, et al. Electrocardiographic and morphometric features in patients with veniculartachycardia of right ventricular origin. Heart, 1998,79(4): 388～393.
6[6]Coumbe A,Perez-Martinez AL, Fegan AW,et al. Arrhythmogenicright ventricular dysplasia(ARVD): an overlooked and underdiagnosed condition? Med Sci Law, 1997,37(3) :262～265.
7[7]OhveiraM, da Silva N, Antunes E, etal.[Guidedanti-arrhythmia therapy by programmed ventricular stimulation. A case ofarrhythmogenic dysplasia of the fight ventricle]. Rev Port Cardiol, 1997,16(1) :33～38.
8[8]peters S, Peters H, Thieerflder L. Risk stratification of suddencardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol, 1999,71 (3):243～250.
9[9]Hayashi K, Sone T, Suzuki T, et al. A case of amiodarone-induced thyrotoxicosis successfully treated with prednisolone. JpnCirc J, 1997,61(4) :361～366.
10[10]Naik Am, Vora AM, Lokhandwala YY, et al. Arrhythmogenicright ventricular dysplasia: electrophysiologic and morphologicfeatures in nine patients. Indian Heart J, 1998,50(4) :423～427.
